πŸ‡ΊπŸ‡Έ FDA
Patent

US 12129307

HER-2 binding antibodies

granted A61KA61K2039/505A61P

Quick answer

US patent 12129307 (HER-2 binding antibodies) held by MAB Discovery GmbH expires Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MAB Discovery GmbH
Grant date
Tue Oct 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61P, A61P35/00, A61P35/04